These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Vitamin D treatment and renal osteodystrophy: indications and modalities]. Fournier A; Morinière P; Yverneau-Hardy P; Westeel PF; Mazouz H; el Esper N; Ghazali A; Boudailliez B Nephrologie; 1995; 16(2):165-90. PubMed ID: 7753302 [TBL] [Abstract][Full Text] [Related]
8. Parathyroidectomy in uraemic hyperparathyroidism: a clinical study. Taylor J; Gunn A; Mactier RA; Henderson IS; Stewart WK Scott Med J; 1992 Feb; 37(1):18-21. PubMed ID: 1574690 [TBL] [Abstract][Full Text] [Related]
9. [Opinionnaire survey on the treatment of renal osteodystrophy in Japan]. Morii H Nihon Jinzo Gakkai Shi; 1983 Apr; 25(4):439-47. PubMed ID: 6620696 [No Abstract] [Full Text] [Related]
10. Can renal bone disease be prevented? Shaldon S Proc Eur Dial Transplant Assoc; 1973; 10(0):91-123. PubMed ID: 4808119 [No Abstract] [Full Text] [Related]
11. Disappearance of vascular calcifications during treatment of renal osteodystrophy. Two patients treated with high doses of vitamin D and aluminum hydroxide. Verberckmoes R; Bouillon R; Krempien B Ann Intern Med; 1975 Apr; 82(4):529-33. PubMed ID: 1119767 [TBL] [Abstract][Full Text] [Related]
12. [Phosphate binders for therapy of hyperphosphatemia causing secondary hyperparathyroidism and renal osteodystrophy in patients with chronic renal failure]. Kanagawa S; Yosikawa Y; Dohi Y Nihon Rinsho; 1991 Dec; 49 Suppl():770-4. PubMed ID: 1808348 [No Abstract] [Full Text] [Related]
13. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients. Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523 [TBL] [Abstract][Full Text] [Related]
14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
15. Fluoride and dialysis osteodystrophy: results of a double-blind study. Oreopoulos DG; Taves DR; Rabinovich S; Meema HE; Murray T; Fenton SS; deVeber GA Trans Am Soc Artif Intern Organs; 1974; 20A():203-8. PubMed ID: 4615422 [No Abstract] [Full Text] [Related]
16. [Role of calcium carbonate in the treatment of renal osteodystrophy]. Morinière P; Boudailliez B; Westeel PF; Achard JM; Djerad M; Nahle M; Amar M; Fournier A Nephrologie; 1991; 12(1):31-41. PubMed ID: 2034319 [No Abstract] [Full Text] [Related]
17. Renal osteodystrophy in children: progress in its management. Chan JC Clin Pediatr (Phila); 1976 Nov; 15(11):996-1002. PubMed ID: 975714 [No Abstract] [Full Text] [Related]